SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-24-006150
Filing Date
2024-04-29
Accepted
2024-04-29 17:07:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20240429xdefa14a.htm DEFA14A 12233
2 GRAPHIC tmb-20240429xdefa14a_bg001.jpg GRAPHIC 157265
3 GRAPHIC tmb-20240429xdefa14a_bg002.jpg GRAPHIC 141895
  Complete submission text file 0001558370-24-006150.txt   425889
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36860 | Film No.: 24892500
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)